<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "dacarbazine inj VIAL>
<dose><value>375</value>
<value>1200</value>
<value>220</value>
<value>1000</value>
<value>850</value>
<value>250</value>
<value>600</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drug><value>dacarbazine inj VIAL</value>
</drug><strength><value>600 mg</value>
</strength><frequency><value>ONCE</value>
<value>DAILY</value>
</frequency><instruction><value></value>
<value>Administer over 2 hours diluted in 1000 mL D5W.</value>
<value>for 3 days. Administer dose over 1 to 2 hours diluted in 250 mL 0.9% sodium chloride.</value>
<value>for 3 days. Administer dose over 1 hour diluted in 250 mL 0.9% sodium chloride.</value>
<value>Administer dose over 1 hour.</value>
<value>for 5 days. Administer dose over 1 hour.</value>
<value>for 3 days. Administer dose over 1 hour diluted in 250 mL D5W.</value>
<value>for 2 doses. </value>
</instruction><volume><value></value>
</volume><units><value>mg/m2</value>
<value>mg/m2/day</value>
</units><additionalnotes><value>Hodgkin&amp;apos;s Lymphoma. For doses less than or equal to 1500mg, dilute dose in 500 mL 0.9% sodium chloride and administer over 1 hour. For doses greater than 1500 mg, dilute dose in 1000 mL 0.9% sodium chloride and administer over 1.5 to 2 hours.</value>
<value>Sarcoma -Osteo. </value>
<value>Metastatic Melanoma</value>
<value>Melanoma</value>
<value>Metastatic Melanoma. For doses less than or equal to 1500mg, dilute dose in 500 mL 0.9% sodium chloride and administer over 1 hour. For doses greater than 1500 mg, dilute dose in 1000 mL 0.9% sodium chloride and administer over 1.5 to 2 hours.</value>
<value>Melanoma. For doses less than or equal to 1500mg, dilute dose in 500 mL D5W. For doses greater than 1500 mg, dilute dose in 1000 mL D5W.</value>
<value>Malignant Melanoma</value>
<value>Pheochromocytoma/Paraganglioma. For doses less than or equal to 1500mg, dilute dose in 500 mL D5W and administer dose over 1 to 1.5 hours. For doses greater than 1500 mg, dilute dose in 1000 mL D5W and administer dose over 1.5 to 2 hours.</value>
</additionalnotes><population><value>ADULT</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3369</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose><value>YES</value>
</maximumprndose></drug>